Artificial Intelligence

Aravo launches its Advantage service to fix a costly enterprise problem: third-party risk programs that stall and fail to deliver on their promise.

After its Alzheimer's drug failed amidst controversy, Cassava Sciences rebrands as Filana Therapeutics, betting its future on a rare epilepsy disorder.

New analysis of Phase 1 data for NKGen Biotech’s troculeucel suggests cognitive benefits, offering a potential new weapon against neuroinflammation.

With its new Disaggregated Spine architecture and ultra-efficient switches, Nexthop AI aims to slash costs and power use for hyperscalers and NeoClouds.

In a tough PE climate, Truelink Capital rapidly closes its second fund at its $2B hard cap, signaling strong investor belief in its operational strategy.

Greenway Health launches Novare, an AI-native system aiming to replace legacy EHRs and eliminate administrative burnout. Is this the future of medicine?

A new report shows automakers are racing to innovate with AI, but a troubling decline in safety standard adherence puts the industry at a critical crossroads.

In the quest to drug the 'undruggable,' Erasca consolidates worldwide control of its promising pan-RAS inhibitor, setting the stage for a global showdown.

The world's largest prediction market is partnering with a controversial data giant to ensure integrity. But what is the price of a clean market?

A new AI biomarker analyzes blood vessels in CT scans, offering earlier, more accurate predictions of which patients will benefit from immunotherapy.

United Airlines takes its corporate billing program, powered by TreviPay, to Europe and ANZ, offering a cost-free solution to complex B2B travel payments.

With NCQA Prevalidation for its ARC platform, COPE Health Solutions offers health plans a streamlined path to accreditation and a trusted tool for VBC.

Cybersecurity leader Forescout unveils a new platform to automate security audits, promising to replace spreadsheets with continuous, real-time compliance.

A new federal directory aims to bring trust and safety to health apps for 68 million seniors, with standards championed early by the osteopathic community.

National Vision's annual scholarship rewards optometry students exploring AI and telemedicine, revealing a strategic investment in the future of eye care.

Sam Lyman, a former top Treasury advisor, is now BPI's Head of Research, a move that cements Bitcoin's role in D.C.'s strategic and economic future.

A new campaign by Palvella Therapeutics and key partners aims to educate and empower patients with a rare disease, a strategic move ahead of a potential new drug.

Kiddie Academy's "STEM Adventures" offers free, hands-on science events nationwide, blending community outreach with a strategy to lead in early education.

Sabre appoints Niklas Andréen as CCO to accelerate airline adoption of its new AI-native tech, signaling a strategic pivot from development to execution.

As quantum threats and automation demands reshape cybersecurity, Sectigo appoints a new leader to capitalize on record growth and guide its global expansion.